Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the rat
Marta Oknińska(Postgraduate School of Molecular Medicine), Michał Ma̧czewski(Postgraduate School of Molecular Medicine), Adam Torbicki(European Hospital), Małgorzata Grzanka(Postgraduate School of Molecular Medicine), Filip Rolski(Postgraduate School of Molecular Medicine), Marcin Kurzyna(Institute of Plasma Physics and Laser Microfusion), Zuzanna Zambrowska(Postgraduate School of Molecular Medicine), Claudine Kiéda(National Academy of Medicine), Agnieszka Piekiełko‐Witkowska(Postgraduate School of Molecular Medicine), Aleksandra Paterek(Postgraduate School of Molecular Medicine), Mateusz Surzykiewicz(Postgraduate School of Molecular Medicine), Karolina Zajda(Narodowy Instytut Leków)
Cited by 2
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k